BSGSX
Price
$15.90
Change
+$0.14 (+0.89%)
Updated
Jul 25 closing price
Net Assets
149.74M
PMAQX
Price
$48.54
Change
+$0.35 (+0.73%)
Updated
Jul 25 closing price
Net Assets
33.03B
Interact to see
Advertisement

BSGSX vs PMAQX

Header iconBSGSX vs PMAQX Comparison
Open Charts BSGSX vs PMAQXBanner chart's image
Baird Small/Mid Cap Growth Investor
Price$15.90
Change+$0.14 (+0.89%)
VolumeN/A
Net Assets149.74M
Principal MidCap R6
Price$48.54
Change+$0.35 (+0.73%)
VolumeN/A
Net Assets33.03B
BSGSX vs PMAQX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BSGSX vs. PMAQX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSGSX is a Buy and PMAQX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 33B vs. BSGSX (150M). PMAQX pays higher dividends than BSGSX: PMAQX (0.19) vs BSGSX (0.00). BSGSX was incepted earlier than PMAQX: BSGSX (7 years) vs PMAQX (9 years). BSGSX (1.18) is less costly to investors than PMAQX (0.59). BSGSX is a more actively managed with annual turnover of: 78.00 vs. PMAQX (10.50). PMAQX has a lower initial minimum investment than BSGSX: PMAQX (0) vs BSGSX (2500). PMAQX annual gain was more profitable for investors over the last year : 13.16 vs. BSGSX (3.14). PMAQX return over 5 years is better than : 57.67 vs. BSGSX (14.53).
BSGSXPMAQXBSGSX / PMAQX
Total Expense Ratio1.100.59186%
Annual Report Gross Expense Ratio1.180.59200%
Fund Existence7 years9 years-
Gain YTD-6.9667.977-87%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets150M33B0%
Annual Yield % from dividends0.000.19-
Returns for 1 year3.1413.1624%
Returns for 3 years5.2149.7610%
Returns for 5 years14.5357.6725%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHSCP27.720.17
+0.62%
CHS
NLOP33.420.19
+0.57%
Net Lease Office Properties
CLDX23.350.13
+0.56%
Celldex Therapeutics
MUR26.13-0.20
-0.76%
Murphy Oil Corp
IPSC0.63-0.03
-5.17%
Century Therapeutics